Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial

OBJECTIVE: Most individuals with type 2 diabetes also have obesity, and treatment with some diabetes medications, including insulin, can cause further weight gain. No approved chronic weight management medications have been prospectively investigated in individuals with overweight or obesity and ins...

Descripción completa

Detalles Bibliográficos
Autores principales: Garvey, W. Timothy, Birkenfeld, Andreas L., Dicker, Dror, Mingrone, Geltrude, Pedersen, Sue D., Satylganova, Altynai, Skovgaard, Dorthe, Sugimoto, Danny, Jensen, Camilla, Mosenzon, Ofri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Emerging Therapies: Drugs and Regimens
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171937/
https://www.ncbi.nlm.nih.gov/pubmed/32139381
http://dx.doi.org/10.2337/dc19-1745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171937/
https://www.ncbi.nlm.nih.gov/pubmed/32139381
http://dx.doi.org/10.2337/dc19-1745

Ejemplares similares